Dr. Michael Meneghini is a renowned orthopedic surgeon and educator, recognized for his pioneering contributions to outpatient joint replacement and computer-assisted surgical techniques.
As the founder and CEO of the Indiana Joint Replacement Institute (IJRI), he has positioned the institute as a leader in orthopedic care and joint replacement. A clinical and thought leader in cutting-edge end-to-end joint replacement, Dr. Meneghini has made significant contributions to peer-reviewed research and has been actively involved in clinical and industry conferences, as well as educational institutions. He currently serves as the Vice President of the American Association of Hip and Knee Surgeons (AAHKS) and will assume the role of President in February 2025.
Recently, IJRI forged a partnership with Healthcare Outcomes Performance Company (HOPCo), a premier provider of musculoskeletal practice management and clinical outcomes solutions in the U.S. This collaboration will enhance IJRI’s clinical operations and flagship surgical center by leveraging HOPCo’s Complete Network Solutions (CNS). Through this partnership, IJRI will gain access to advanced performance data analytics, customized electronic medical records, and comprehensive IT and cybersecurity solutions, further solidifying its commitment to delivering high-quality orthopedic care.
In addition to this collaboration, Dr. Meneghini will serve as HOPCo’s Chief Market Development Officer, focusing on developing physician practice partnerships and supporting growth initiatives. Both Dr. Meneghini and HOPCo are enthusiastic about the new opportunities this partnership will create for both IJRI and HOPCo, fostering innovation and excellence in orthopedic care.
Q: Why did you decide to partner with HOPCo?
Dr. Meneghini: There are a number of reasons why HOPCo was the ideal partner for IJRI. First, a trusted, talented and innovative group of executives that I have known well as colleagues and friends for almost 20 years. Second, my background as a founder and executive in a more traditional private equity management service for orthopedic practices made me particular about how we secured capital and resources to manage and scale our practices. I was very interested in partnering with an organization that could bring extensive value to IJRI’s surgeons and providers that was above and beyond what financial institutions or hospital systems could offer. HOPCo’s unique platform not only provides necessary capital and infrastructure to grow and scale, but more importantly, it’s differentiated applied technology and digital solutions including - a proprietary orthopedic-focused EMR, the myrecovery by HOPCoTM patient engagement and PROM collection platform, HOPCo Vitals operational analytics software, Complete Network Solutions IT management services, and unmatched value-based-care division - will drive additional revenue generation for IJRI. Honestly, HOPCo stands in a league of its own related to what they offer orthopedic practices in the modern era of healthcare…the decision was a “no brainer”.
Q: What does this partnership mean between the two organizations and how do you think it will benefit both IJRI and HOPCo?
Dr. Meneghini: I am confident that both organizations will benefit from this partnership. IJRI will benefit by gaining access to the resources and talent in the largest and most trusted value-based care organization in musculoskeletal care, which will allow our practice, surgeons and patients to flourish and succeed in the challenging healthcare landscape. HOPCo will benefit in gaining a nationally and internationally renowned state-wide hip and knee replacement practice that produces the highest level of quality patient care, research and education and has established success in value-based care models.
Q: As part of this partnership, you’ll serve as HOPCo’s Chief Market Development Officer. What are your goals for this position?
Dr. Meneghini: I am honored and humbled to serve in this role at HOPCo, joining such a talented and experienced executive team. My goals are to work with HOPCo’s leadership and functional teams to drive growth and development opportunities within all the business units in both national and international markets. As a very busy and efficient hip and knee arthroplasty surgeon with experience in both private practice and academic settings, in addition to my experience as an executive in a successful orthopedic management organization, I have a deep appreciation for the services, resources and capital necessary in today’s healthcare environment. These elements are crucial to effectively care for patients while growing a successful practice and business enterprise. It is my mission and vision to be an advocate for surgeons and patients across the globe by bringing any and all of HOPCo’s turn-key solutions that orthopedic practices need to succeed and flourish in today’s challenging healthcare environment. I am incredibly excited to join the HOPCo team in this capacity and contribute to its skyrocketing growth and success.
Q. IJRI will be using HOPCO Vitals, Complete Network Solutions (CNS) and myrecovery to support operational efficiencies, data insights and patient engagement – how will these solutions help IJRI’s strategic growth?
Dr. Meneghini: These innovative digital platforms will provide our executive team and physician leaders distinct advantages, providing them operational data in real-time to make strategic and operational decisions that help our providers optimize their efficiency, cost-effectiveness, and quality of patient care across the entire organization. Furthermore, streamlining operational efficiencies and enhancing revenue generation will provide additional opportunities and resources that will empower our executive team to focus on strategic and innovative growth initiatives in partnership with HOPCo. This includes developing new practice-based revenue streams and expansion into new markets. Finally, these digital solutions will support our high-quality providers in delivering exceptional patient care and experiences, enabling optimal patient outcomes and driving growth through the most market-disruptive means: patient to patient referrals.